← Leaderboards
Dusan Hanidziar
Beth Israel Deaconess Medical Center
$1,775,018
Attributed
$1,775,018
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $734.8K · FY2009–25$1M$750K$500K$250K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,775,018 · 4
By mechanism
K08$864,000 · 1
R56$610,236 · 1
R03$249,072 · 1
F32$51,710 · 1
Top collaborators
No co-investigators on record.
Most similar at Beth Israel Deaconess Medical Center
Same institution · by research overlap
- Margaret J Koziel$5,996,609
- Corey S Cutler$6,266,747
- Chen Sabrina Tan$4,716,945
- Shahzad Shaefi$1,037,940
- Anthony P Monaco$4,173,185
Others in their field
Top investigators on “Inflammatory”
- David Heimbrook · Leidos Biomedical Research, Inc.$85,243,263
- Edward A Dennis · University Of California, San Diego$72,701,136
- Constance Ann Benson · University Of California, San Diego$65,790,143
- Randall J Bateman · Washington University$62,939,456
- Paul M. Ridker · Brigham And Women'S Hospital$56,179,451
- Keri Hammel · The Emmes Company, Llc$53,700,408
Research focus
InflammatoryCellsInflammationImmune ResponseImmuneInjuryProductionOxygenLung InjuryPhenotypeInfiltrationNeutrophilPathway InteractionsTissuesMediatingMouse ModelB-LymphocytesIn VivoHyperoxiaLungAlveolarAcute Lung InjuryInvestigationAward
Grant awards (9)
Protective role of B cells in hyperoxic lung injury$124,536
R03 · FY2025 · HL · contact PI
B cells for treatment of ARDS$610,236
R56 · FY2024 · HL · contact PI
Protective role of B cells in hyperoxic lung injury$124,536
R03 · FY2024 · HL · contact PI
Purinergic Modulation of NKT Cells Ameliorates Hyperoxic Lung Injury$172,800
K08 · FY2023 · HL · contact PI
Purinergic Modulation of NKT Cells Ameliorates Hyperoxic Lung Injury$172,800
K08 · FY2022 · HL · contact PI
Purinergic Modulation of NKT Cells Ameliorates Hyperoxic Lung Injury$172,800
K08 · FY2021 · HL · contact PI
Purinergic Modulation of NKT Cells Ameliorates Hyperoxic Lung Injury$172,800
K08 · FY2020 · HL · contact PI
Purinergic Modulation of NKT Cells Ameliorates Hyperoxic Lung Injury$172,800
K08 · FY2019 · HL · contact PI
Role of interleukin 21 in the allograft response$51,710
F32 · FY2009 · AI · contact PI